Evidence map›Paper›PMID 42434150›Full record

ArticleJournal of vitreoretinal diseases2026

Progressive Retinal and Neurologic Findings in a Family With Neuropathy, Ataxia, and Retinitis Pigmentosa Syndrome.

Faizan Naveed, Salem Abu Al-Burak, Erfan Hashemi, Brian G Ballios, Shaheer Aboobaker

Abstract readCase Reports
In one paragraph

Article in Journal of vitreoretinal diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Faizan NaveedFaculty of Medicine, University of Ottawa, Ottawa, ON, Canada.ORCID https://orcid.org/0009-0003-1488-7175
Salem Abu Al-BurakSchulich School of Medicine & Dentistry, Western University, London, ON, Canada.ORCID https://orcid.org/0000-0002-4044-3215
Erfan HashemiToronto Retina Institute, North York, ON, Canada.ORCID https://orcid.org/0000-0002-9119-5143
Brian G BalliosDepartment of Ophthalmology & Vision Science, University of Toronto, Toronto, ON, Canada.ORCID https://orcid.org/0000-0002-4644-3339
Shaheer AboobakerToronto Retina Institute, North York, ON, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To describe the longitudinal ophthalmic findings of a maternally related triad with neuropathy, ataxia, and retinitis pigmentosa and explore potential relationships between phenotype and heteroplasmy levels. Methods: A mother, daughter, and son with genetically confirmed neuropathy, ataxia, and retinitis pigmentosa due to the m.8993T>G MT-ATP6 variant (heteroplasmy levels: 38.8%, 76.8%, and 87%, respectively) were followed for 5 years. Assessments included best-corrected visual acuity, slitlamp examination, dilated fundus examination, optical coherence tomography, widefield color fundus imaging, fundus autofluorescence, full-field and multifocal electroretinography, and Goldmann visual field testing. Results: Longitudinal evaluation demonstrated marked intrafamilial variability. Patient 1 demonstrated widespread ellipsoid zone loss and rod-cone dysfunction; Patient 2 exhibited retinal thinning and cone-predominant dysfunction. Patient 3 showed initially normal retinal structure with subtle fundus autofluorescence changes and mild asymmetric functional loss. Conclusions: Despite harboring the same pathogenic MT-ATP6 variant, affected family members exhibited substantial variability in ophthalmic disease severity. Clinical manifestations did not correlate with blood heteroplasmy levels, highlighting the importance of longitudinal multimodal ophthalmic surveillance in patients with neuropathy, ataxia, and retinitis pigmentosa.

Indexed as

and retinitis pigmentosaataxiacase seriesheteroplasmym.8993T>GMT-ATP6neuropathyretinitis pigmentosa

Identifiers

PMID42434150
PMCPMC13350071

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.